How do you take astaxanthin?
| Source | Amount | Schedule |
|---|---|---|
| Source Naturals maker label1 | 12 mg astaxanthin per softgel, 60 to a bottle | 1 softgel daily with a meal |
| EFSA opinion4 | 8 mg astaxanthin at most (oleoresin at 40 to 80 mg) in EU food supplements | Per day |
Strengths and what labels and regulators give
The table is set at the top of the page
The same EFSA opinion concluded that adolescents aged 14 and over reach the acceptable daily intake (ADI) in a combined exposure scenario, that the ADI is exceeded in children below 14 years of age, and that 8 mg a day from food supplements is safe for adults even with a high background intake from the diet.4 The Source Naturals 12 mg softgel is the only maker label saved for this guide;1 other strengths appear only as trial capsules, not products found on sale.
Doses used in human trials
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Hecht 2025 (children's digital eye strain)2 | 4 mg soft capsule daily, against placebo | 64 children aged 10 to 14 with at least 4 h of daily screen time and mild to moderate computer vision syndrome symptoms | 84 days |
| Kumalic 2020 (men's semen)5 | 16 mg a day, against placebo | Eighty infertile men with oligo-astheno-teratozoospermia, 72 completing (37 astaxanthin, 35 placebo) | three months |
| Choi 2011 (oxidative stress)3 | 5 mg or 20 mg once daily, two dose groups, compared with baseline | Twenty-three overweight and obese adults in Korea (BMI over 25.0 kg/m2) | 3 weeks |
| Urakaze 2021 (glucose metabolism)6 | 12 mg once daily, against placebo | 53 healthy or prediabetic subjects | 12 weeks |
| Shafie 2024 (poor ovarian response)7 | 12 mg a day, against placebo | 60 infertile women over 35 with poor ovarian response undergoing intracytoplasmic sperm injection | eight weeks |
| Ciaraldi 2023 (prediabetes and dyslipidaemia)8 | 12 mg daily, against placebo | 34 adults (22 treated, 12 placebo) | 24 weeks |
A search of PubMed, ClinicalTrials.gov and EFSA found no cycling schedule and no stated maximum duration; the longest trial in the table ran 24 weeks.8
With food, and the form
A 2003 open parallel study by Mercke Odeberg and colleagues, in which healthy male volunteers took a single 40 mg dose, notes in its background that bioavailability can be enhanced in the presence of fat; its three lipid based formulations (palm oil or glycerol mono- and dioleate, with polysorbate 80) gave 1.7 to 3.7 times the bioavailability of a commercially available food supplement, which compares formulations and not meals.9 A search found no direct comparison of taking astaxanthin with and without food.
Powder, mixing and syringes
A search of DailyMed, PubMed and the maker label found no instruction for mixing an astaxanthin powder, and the products found are oral softgels, capsules or tablets. A search found no vial or injectable concentration for astaxanthin, so no syringe arithmetic applies; the units and dosing guide covers syringes for compounds that have one. A 2024 crossover pharmacokinetic study by Khayyal and colleagues gave 12 healthy male volunteers a single 400 mg capsule equal to 8 mg astaxanthin with 240 mL water after a 10 h fast, which is a study procedure and not a mixing instruction.10
Storage
The maker label says to store in a cool, dry place,1 and a search of the maker label, DailyMed and EFSA found no storage condition after opening or mixing. The same label asks anyone who is pregnant, may become pregnant or is breastfeeding to consult a health care professional before using the product.1
Frequently asked questions
Is there an approved astaxanthin label?
The only US label found in DailyMed is Tobakient, a multi-ingredient prescription vitamin capsule containing astaxanthin for the clinical dietary management of suboptimal nutritional status, with a usual adult dose of one capsule once or twice daily or as prescribed by a licensed medical practitioner; its label says it is not an Orange Book product and its claims are not drug claims.11 A search of DailyMed, ClinicalTrials.gov and PubMed found no single-ingredient approved drug label.
What daily amount is acceptable to EFSA?
EFSA's feed panel set an acceptable daily intake (ADI) of 0.2 mg astaxanthin per kg body weight per day, which replaced the ADI of 0.034 mg/kg body weight set in 2014.4
What does EFSA say about children?
EFSA's 2025 opinion on algal meal says that when supplement intake is added to the background diet and the intended new uses in dairy analogues and fruit juices, the combined intake from all three exceeds the ADI for children aged 3 and over and for adolescents, and is at the level of the ADI for adults.12
What dose did skin trials use?
A 2021 meta-analysis of skin randomised trials reports two studies at 2 mg/d astaxanthin with other antioxidants and other studies at 4 mg/d to 12 mg/d as oral capsules, lasting 4 to 16 weeks.13 It calls for future studies applying various doses of oral astaxanthin to investigate if there is a dose-response effect in humans.13
References
- NIH Dietary Supplement Label Database (Source Naturals label). S O U R C E N A T U R A L S®. api.ods.od.nih.gov
- PubMed. Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial. 2025. pubmed.ncbi.nlm.nih.gov
- PubMed. Effects of astaxanthin on oxidative stress in overweight and obese adults. 2011. pubmed.ncbi.nlm.nih.gov
- EFSA Journal (EFSA NDA Panel). Safety of astaxanthin for its use as a novel food in food supplements. 2020. pmc.ncbi.nlm.nih.gov
- Radiology and Oncology. Effect of the Oral Intake of Astaxanthin on Semen Parameters in Patients with Oligo-astheno-teratozoospermia: A Randomized Double-blind Placebo-controlled Trial. 2020. pmc.ncbi.nlm.nih.gov
- PubMed. The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes. 2021. pubmed.ncbi.nlm.nih.gov
- PubMed. Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial. 2024. pubmed.ncbi.nlm.nih.gov
- PubMed. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia. 2023. pubmed.ncbi.nlm.nih.gov
- PubMed. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. 2003. pubmed.ncbi.nlm.nih.gov
- European Journal of Drug Metabolism and Pharmacokinetics. Comparative Pharmacokinetic Study of Standard Astaxanthin and its Micellar Formulation in Healthy Male Volunteers. 2024. pmc.ncbi.nlm.nih.gov
- Levins Pharmaceuticals, LLC via DailyMed (US label). Tobakient. 2019. dailymed.nlm.nih.gov
- EFSA Journal (EFSA NDA Panel). Safety of algal meal from Haematococcus pluvialis containing astaxanthin as a novel food pursuant to Regulation (EU) 2015/2283. 2025. pmc.ncbi.nlm.nih.gov
- Nutrients. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. 2021. pmc.ncbi.nlm.nih.gov